|
| Status |
Public on Jan 09, 2024 |
| Title |
Patient26 10002-Nivo |
| Sample type |
RNA |
| |
|
| Source name |
HNSCC
|
| Organism |
Homo sapiens |
| Characteristics |
gender: Female
age (years): 65
site: Alveolus
sample type: Primary
therapy: Neoadjuvant CT/RT
cancer grade: Grade-1
cancer stage: IVA
cohort: SC2a
treatment in culture: Nivolumab
|
| Treatment protocol |
Samples were either untreated (Control), Nivolumab treated (Nivo) or Nivolumab+Ipilimumab treated (N+I)
|
| Growth protocol |
Ex vivo culture for 72 hours
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted from FFPE blocks.
|
| Label |
n/a
|
| Label protocol |
n/a
|
| |
|
| Hybridization protocol |
Manufacturer's protocol was followed
|
| Scan protocol |
Digital analyser is used for the scanning of catridge.
|
| Data processing |
nSolver software was used to normalise the data against the selected 5 specific housekeeping genes DNAJC14, GUSB, NRDE2, TFRC, UBB.
|
| |
|
| Submission date |
Jun 05, 2023 |
| Last update date |
Jan 09, 2024 |
| Contact name |
Nandini Pal Basak |
| E-mail(s) |
[email protected]
|
| Organization name |
Farcast Biosciences
|
| Department |
R&D
|
| Street address |
Hosur road
|
| City |
Bangalore |
| State/province |
Karnataka |
| ZIP/Postal code |
560100 |
| Country |
India |
| |
|
| Platform ID |
GPL27956 |
| Series (2) |
| GSE234136 |
Capturing the dynamic interactions between tumor and immune components of the tumor micro-environment is important for determining efficacy of anti-PD1 treatment [Post Culture_Metadata] |
| GSE234138 |
Capturing the dynamic interactions between tumor and immune components of the tumor micro-environment is important for determining efficacy of anti-PD1 treatment |
|
